The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)

EuroIntervention 2009;5:224-232. DOI: 10.4244/EIJV5I2A36

1. Middelheim Hospital Antwerp, Belgium; 2. Cardiovascular Center Aalst, Belgium; 3. HELIOS Klinikum Siegburg, Germany; 4. Schwarzwald-Baar Klinikum Villingen-Schwenningen, Germany; 5. University Hospital Antwerp, Belgium; 6. Genae Associates Antwerp, Bel

Aims: The aim of this multicentre, non-randomised trial was to evaluate the safety and efficacy at 180±14 days of a pimecrolimus eluting coronary stent based on a cobalt-chromium platform a

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention